Th
Third Rock
Boston MAFounded 200750 employees
Private CapbiotechPrivateOncology
Platform: Health VC
Market Cap
N/A
All Drugs
4
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Olpaglumide | THI-9406 | Phase 2/3 | 1 | SHP2 | RCCAtopic Derm | ||
| THI-2182 | THI-2182 | Phase 1/2 | 1 | BTK | ACC | ||
| Tirasertib | THI-8438 | Phase 1/2 | 1 | BCMA | WilmsMG | ||
| THI-6273 | THI-6273 | Phase 2 | 2 | CD19 | Huntington'sACC |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (2)